New injection Y-3 tested for drug interactions in healthy volunteers
NCT ID NCT07068841
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This completed Phase 1 trial studied whether Y-3 for injection changes how the body processes three common drugs (repaglinide, warfarin, and omeprazole) in 24 healthy Chinese adults. Participants took these drugs with and without Y-3 to measure blood levels and safety. The goal is to provide dosing guidance for future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
Conditions
Explore the condition pages connected to this study.